Daojun Yu
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Microbiology top 10%
- Bacterial Infections and Vaccines
Papers in
-
- Antibiotic Resistance in Bacteria 9
- Epidemiology 11
- Sepsis Diagnosis and Treatment 3
- Hepatitis B Virus Studies 3
- Respiratory viral infections research 2
- Co-authors
- Yueming Chen (10 shared papers)Xueyan Dong (5 shared papers)Xianjun Wang (4 shared papers)Xianjun Wang (5 shared papers)Songzhe He (3 shared papers)Weiying Zhang (2 shared papers)Wenxia Shao (2 shared papers)Hui He (2 shared papers)
- Journals
- Frontiers in Microbiology (4 papers)Scientific Reports (3 papers)Biological Trace Element Research (3 papers)Diagnostic Pathology (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Daojun Yu
48 papers receiving 681 citations
Peers
Comparison fields: 5 of 92
- Molecular Medicine 97
- Microbiology 42
- Pollution 57
- Infectious Diseases 80
- Endocrinology 14
Countries citing papers authored by Daojun Yu
This map shows the geographic impact of Daojun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daojun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daojun Yu more than expected).
Fields of papers citing papers by Daojun Yu
This network shows the impact of papers produced by Daojun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daojun Yu. The network helps show where Daojun Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Daojun Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 81 | |
| 2 | 2017 | 75 | |
| 3 | 2022 | 44 | |
| 4 | 2024 | 38 | |
| 5 | 2015 | 34 | |
| 6 | Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. | 2015 | 32 |
| 7 | 2015 | 25 | |
| 8 | 2013 | 22 | |
| 9 | 2016 | 21 | |
| 10 | 2019 | 21 | |
| 11 | Case report: Staphylococcus gallinarum bacteremia in a patient with chronic hepatitis B virus infection. | 2008 | 19 |
| 12 | 2018 | 18 | |
| 13 | 2020 | 17 | |
| 14 | 2023 | 16 | |
| 15 | 2008 | 15 | |
| 16 | 2022 | 15 | |
| 17 | 2008 | 14 | |
| 18 | HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China. | 2012 | 12 |
| 19 | 2012 | 12 | |
| 20 | 2020 | 11 |
About Daojun Yu
Daojun Yu is a scholar working on Molecular Medicine, Epidemiology, Endocrinology, Clinical Biochemistry and Microbiology, having authored 51 papers that have together received 693 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Bacterial biofilms and quorum sensing (5 papers), Kidney Stones and Urolithiasis Treatments (4 papers), Sepsis Diagnosis and Treatment (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Hepatitis B Virus Studies (3 papers), Heavy Metal Exposure and Toxicity (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Molecular Medicine (97 citations), Microbiology (42 citations), Pollution (57 citations), Infectious Diseases (80 citations) and Endocrinology (14 citations). Daojun Yu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Yueming Chen, Xueyan Dong, Xianjun Wang, Xianjun Wang, Songzhe He, Weiying Zhang, Wenxia Shao, Hui He, Haitong Wan and Shenghai Wu. Their work appears in journals such as Frontiers in Microbiology, Scientific Reports, Biological Trace Element Research, Diagnostic Pathology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.